The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare's CT-P13 (biosimilar infliximab
) in patients with Crohn's disease is comparable to those treated with reference infliximab
as well as those treated with adalimumab.
Remicade, MSD's version of the medicine infliximab
, is used to treat patients with gastroenterology and rheumatoid conditions, including Crohn's disease, ulcerative colitis and rheumatoid arthritis.
The first product, the Quantum Blue[R] Infliximab
is a quantitative flow rapid test assay designed with an innovative solution based on established lateral flow technology which utilizes highly specific monoclonal antibodies to capture the molecule being measured.
El objetivo del presente estudio es dar a conocer sobre la eficacia y ventajas de la nueva terapia anti-TNF, el adalimumab, en una paciente resisten te al infliximab
, sobre el que todavia no hay muchos estudios que describan su eficacia en este sindrome de VKH refractario.
In the first month after the herpetic keratouveitis attack, trabeculectomy with mitomycin C was performed about halfway through an eight-week interval between two doses of infliximab
Due to long neonatal half life, infliximab
levels became undetectable in infant serum only between 2-7 months, compared with 1-2 weeks in adults.
During this hospitalization, the 6-mercaptopurine and infliximab
were discontinued, but the patient remained on low dose corticosteroids.
Herein, we present a resistant PG lesion associated with ulcerative colitis and spondylitis which favorably responded to infliximab
Keywords: Behcet\'s disease, Ocular disease, Uveitis, Infliximab
, Anti TNF-alpha drugs.
Adalimumab is the second TNF blocker to be approved for ulcerative colitis; infliximab
(Remicade), an intravenous TNF blocker, was previously approved for treating UC.
SILVER SPRING, MD -- A Food and Drug Administration advisory panel has backed the approval of infliximab
to treat ulcerative colitis in children and adolescents.
In this article, we describe our investigation of the use of the cytotoxic agent infliximab
in patients with treatment-refractory AISNHL
TNF-[alpha] inhibitors include infliximab
and adalimumab, which are among monoclonal antibodies, and etanercept in receptor form.
Washington, April 20(ANI): Researchers have been successful in treating cystic fibrosis and Crohn's disease with infliximab
JAPAN -- Infliximab
(Remicade[R]) is a monoclonal antibody used to treat autoimmune disorders against tumor necrosis factor-alpha (TNF-[alpha]).